- $183.74m
- $174.37m
- $32.38m
Brief: Stereotaxis Announces CE Mark Submission For Robotically Navigated Magic Ablation Catheter
Brief: Stereotaxis Reports 2022 First Quarter Financial Results
Brief: Stereotaxis Reports 2021 Full Year Financial Results
Brief: Stereotaxis Reports Qtrly Loss Per Share Of $0.07
Brief: Stereotaxis Inc Announced Installation Of Its Genesis Robotic Magnetic Navigation (Rmn) System At Princess Grace Hospital Center In Monaco
Brief: Stereotaxis And Microport EP Collaborate On Robotic Electrophysiology In China
Brief: Stereotaxis Reports Qtrly Loss Per Share $0.02
Brief: Stereotaxis Reports 2020 Full Year Financial Results
Brief: Stereotaxis Reports Long-Term CEO Performance Stock Award
Brief: Stereotaxis Reports Q3 Loss Per Share Of $0.03
AMEX HALT EQUIPMENT CHANGEOVER LAST 3.21000
Brief: Stereotaxis To Be Added To The Russell 2000 And Russell 3000 Indexes
Brief: Stereotaxis Announces $15 Million Common Stock Financing
Brief: Stereotaxis Reports Qtrly Loss Per Share Of $0.03
AMEX RESUMED
Brief: Stereotaxis Earns FDA Clearance For Genesis Robotic Magnetic Navigation System
Brief: Stereotaxis Q3 Revenue Rose 9 Percent To $8.2 Million
Brief: Stereotaxis And Catheter Precision Combine Robotic Navigation And Preoperative Arrhythmia Localization To Treat Cardiac Arrhythmias
Brief: Stereotaxis Files Prospectus For Resale Of Up To 12.2 Million Shares